BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37976762)

  • 1. Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes.
    Wang Z; Zhu W; Yang M; Du H; Zhou F; Song N; Wan Z; Zhu J; Li W
    Eur J Radiol; 2023 Dec; 169():111194. PubMed ID: 37976762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Sun K; Li M; Shang M; Su X; Zhao J; Wang B; Wu C; Zhang L; Yang S; Sun X
    Lung Cancer; 2022 Apr; 166():63-69. PubMed ID: 35196635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of air bronchogram is a novel predictor of negative nodal involvement in radiologically pure-solid lung cancer.
    Hattori A; Suzuki K; Maeyashiki T; Fukui M; Kitamura Y; Matsunaga T; Miyasaka Y; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):699-702. PubMed ID: 24135955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
    Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
    Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang H; Cai W; Wang Y; Liao M; Tian S
    Int J Clin Oncol; 2019 Jun; 24(6):649-659. PubMed ID: 30835006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
    Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
    J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
    Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
    Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?
    Kim W; Lee SM; Lee JB; Seo JB; Kim HK; Kim J; Lee HY
    Korean J Radiol; 2022 Mar; 23(3):370-380. PubMed ID: 35213098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
    Yang F; Sun K; Li F; Li X; Shi J; Sun X; Hong Y; Jiang G; Zhu Y; Song X
    Ann Thorac Surg; 2024 Jun; 117(6):1111-1119. PubMed ID: 37353101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.
    Isaka T; Ito H; Nakayama H; Yokose T; Yamada K; Masuda M
    Lung Cancer; 2020 Jul; 145():111-118. PubMed ID: 32428800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
    Rizzo S; Petrella F; Buscarino V; De Maria F; Raimondi S; Barberis M; Fumagalli C; Spitaleri G; Rampinelli C; De Marinis F; Spaggiari L; Bellomi M
    Eur Radiol; 2016 Jan; 26(1):32-42. PubMed ID: 25956936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery.
    Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Adachi H; Miura J; Shigefuku S; Kikuchi A; Rino Y
    Lung Cancer; 2021 Dec; 162():128-134. PubMed ID: 34775216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status.
    Isaka T; Ito H; Yokose T; Saito H; Adachi H; Murakami K; Miura J; Kikunishi N; Rino Y
    BMC Cancer; 2022 Sep; 22(1):966. PubMed ID: 36085020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 19. Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection.
    Yoshino I; Nakanishi R; Kodate M; Osaki T; Hanagiri T; Takenoyama M; Yamashita T; Imoto H; Taga S; Yasumoto K
    Int Surg; 2000; 85(2):105-12. PubMed ID: 11071324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.